Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.

被引:0
|
作者
Nagy, AJ
Wang, ZG
Maslak, P
Chanel, S
Ho, R
Spriggs, D
Tong, W
Ellison, R
Pandolfi, PP
Warrell, RP
Soignet, SL
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] PolaRx Biopharmaceut Inc, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:100A / 100A
页数:1
相关论文
共 50 条
  • [21] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
    Iland, Harry J.
    Seymour, John F.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 170 - 184
  • [22] Treatment of acute promyelocytic leukemia with arsenic trioxide
    Tamm, I
    Paternostro, G
    Zapata, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13): : 1043 - 1043
  • [23] Arsenic trioxide: Acute promyelocytic leukemia and beyond
    Bachleitner-Hofmann, T
    Kees, M
    Gisslinger, H
    LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1535 - 1540
  • [24] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
    Harry J. Iland
    John F. Seymour
    Current Treatment Options in Oncology, 2013, 14 : 170 - 184
  • [25] Arsenic trioxide for the treatment of acute promyelocytic leukemia
    Lam, MSH
    Ignoffo, RJ
    CANCER PRACTICE, 2001, 9 (03) : 155 - 157
  • [26] Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
    Au, Wing Y.
    Li, Chi-Kong
    Lee, Vincent
    Yuen, Hui Leung
    Yau, Jeffrey
    Chan, Godfrey C. F.
    Ha, Shau-yin
    Kwong, Yok-lam
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 630 - 632
  • [27] Pharmacokinetic of arsenic trioxide in newly diagnosed acute promyelocytic leukemia patients
    Hosseini, R.
    Mandegary, A.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Ghahremani, M.H.
    Journal of Applied Sciences, 2008, 8 (24) : 4617 - 4623
  • [28] Evaluation of Mechanisms of Resistance to Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia
    Chendamarai, Ezhilarasi
    Abu Alex, Ansu
    Ganesh, Saravanan
    Lakshmi, Kavitha M.
    Jadhav, Sachin
    George, Biju
    Abraham, Aby
    Balasubramanian, Poonkuzhali
    Ramachandran, Shaji
    Srivastava, Alok
    Mathews, Vikram
    BLOOD, 2010, 116 (21) : 1132 - 1133
  • [29] A phase I/II trial of arsenic trioxide for relapsed and refractory-acute promyelocytic leukemia.
    Westervelt, P
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Rush, C
    Lojka, T
    Miller, G
    DiPersio, JF
    BLOOD, 1998, 92 (10) : 219B - 219B
  • [30] Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia.
    Westervelt, P
    Pollock, J
    Haug, J
    Ley, TJ
    DiPersio, JF
    BLOOD, 1997, 90 (10) : 3859 - 3859